1. Home
  2. In 5 years Modi did nothing but changing names of old schemes: Deve Gowda

In 5 years Modi did nothing but changing names of old schemes: Deve Gowda

News Network
March 17, 2019

Shivamogga , Mar 17: Criticising the Modi-led government in the Centre, JD(S) Supremo and former prime minister H D Deve Gowda stated that the BJP-led government has only changed the names of old schemes and nothing else in the last five years.

BJP has added the term 'Pradhan Mantri' to all the schemes. "But I had not done it during my tenure as prime minister."

He was speaking at JD(S) elected representatives, leaders and workers meeting at Lagan convention hall in the city on Sunday.

Addressing the gathering, he claimed that he headed the 13 parties government in the Centre without paving the way for any communal clash.

It was purely coalition government unlike the present government in the Centre. But there was no clash between Muslims and Hindus and terror attacks. "I don't make personal attacks. But I am just sharing the facts with you."

Referring to the Godhra train burning incident in Gujarat, he said ''that many Muslims were killed, Churches and bible were burnt. But I don't make any provocative statement. I had toured Gujarat for three days in 2002. I had asked SP and deputy commissioner why they did not stop the violence. They had told that there was no instructions from higher-ups. Do we need such governance again in the country?''

Recalling the past, he said he had maintained a good rapport with neighbouring countries during his tenure as prime minister. He was the first prime minister to visit violence-hit Kashmir after a gap of ten years.

The officials of defence forces cautioned that there could be a threat to his life if he visited Kashmir. However, I had visited the valley state and had interacted with the people.

They shared that tourism must be promoted as it has been the source of livelihood for them.

Gowda also promised that he would strive for the victory of Madhu Bangarpapa in the Lok Sabha election to Shivamogga constituency as he is doing it for his grandsons in Hassan and Mandya.

Speaking to media persons, here on Sunday, he said "Madhu is like my son. So I would leave no stone unturned for his victory."

He said major leaders of Congress party including DK Shivakumar would campaign in favour of Madhu in the constituency.

Referring to confusion over Uttara Kannada Lok Sabha constituency, he said senior Congress leader R V Deshpande has spoken to him. But nothing has been finalised yet.

Comments

Abdullah
 - 
Monday, 18 Mar 2019

BJP just fooled the people for last 5 years and assisted in running away of big shots with crores of rupees to get percentage.

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
June 13,2020

Shivamogga, Jun 13: Senior BJP leader and Karnataka Minister for Rural Development and Panchayat Raj, K S Eshwarappa on Saturday opined that during the selection of candidates to the legislative council, the party needs to take into consideration those who helped the party in formation of government in the State.

Speaking to media persons on the sideline of a programme here, he said the party high command would give another surprise while issuing tickets during the MLC election.

Mr Eshwrappa said that party high command will take a call on selecting candidates, but priority should be given to the leader who won on Congress and Janata Dal and then jumped to BJP which helped to form govt under the leadership of B S Yediyurappa.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 30,2020

New Delhi, Jul 29: Air Commodore Hilal Ahmad Rather has become a buzz name in Kashmir overnight. Hilal saw off the first batch of Rafale jets which took off from France to India on Monday. Among other things, he has also been associated with the weaponisation of the Rafale aircraft for acclimatisation to Indian requirements.

Hilal is presently India's Air Attache in France.

The career details of this officer of the Indian Air Force (IAF) read like the decoration scroll of the best flying officer anywhere in the world.

Born in the south Kashmir's Anantnag district to middle-class parents, Hilal's father, late Mohammad Abdullah Rather retired as a deputy superintendent of police (Dy SP) in J&K police department. He has three sisters and is the only son of his parents. Hilal studied in Sainik School in Nagrota town of Jammu district.

He was commissioned in IAF as a fighter pilot on December 17, 1988, became flight lieutenant in 1993, wing commander in 2004, group captain in 2016 and air commodore in 2019.

He graduated from defence services staff college (DSSC). He also graduated from air war college (USA) with distinction. He won the sword of honour in NDA. Hilal is also the recipient of Vayu Sena Medal and Vishisht Seva medal.

With an impeccable record of 3,000 accident-free flying hours on mirage-2000, MIG-21 and Kiran aircraft, Hilal's name will now forever be associated with Rafale in India.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.